Cancer is a life-threatening disease and the leading cause of death worldwide. While there have been significant advances in treating cancer, it is still widely recognized as a leading area of unmet medical needs.
We have both clinical and preclinical programs underway to develop its leading, novel, molecular targeted cancer therapies. Our discovery research is focused on specific oncology targets with a full panel of in vitro and in vivo assays. Multiple compounds are being pursued at different preclinical/discovery/development stages.